×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Atyr Pharma Inc. (LIFE) NASDAQ

$1.91 (0.07) (-3.30%)

Market Cap: $115.36M

As of 02/22/24 03:19 PM EST. Market open.

(LIFE)

Atyr Pharma Inc. (LIFE)
NASDAQ

$1.91
(0.07) (-3.30%)

Market Cap: $115.36M

As of 02/22/24 03:19 PM EST. Market open.

Add to Portfolio

atyr pharma (nasdaq: life) is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology, a newly discovered set of physiological modulators. the company's lead candidate, resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune ... read more

atyr pharma (nasdaq: life) is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology, a newly discovered set of physiological modulators. the company's lead candidate, resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component. resolaris is currently in a phase 1b/2 clinical trial in adult patients with facioscapulohumeral muscular dystrophy (fshd); a phase 1b/2 trial in adult patients with limb girdle muscular dystrophy (lgmd) 2b or fshd; and a phase 1b/2 trial in patients with an early onset form of fshd. to protect this pipeline, atyr built an intellectual property estate comprising 70 issued or allowed patents and over 240 pending patent applications that are solely owned or exclusively licensed by atyr. atyr's key programs are currently focused on severe, rare diseases characterized by immune dysregulation read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Sanjay Shukla
Full Time Employees
80
URL
Address
3545 John Hopkins Ct Ste 250, California, San Diego, 92121-1115.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Sanjay Shukla
Full Time Employees
80
Address
3545 John Hopkins Ct Ste 250, California, San Diego, 92121-1115.
PRICE CHART FOR ATYR PHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.96
Previous Close
$1.97
Days Range
$1.84 - $2.01
52 week range
$1.08 - $2.70
Volume
933,156
Avg. Volume (30 days)
525,351
Market Cap
$115.36M
Dividend Yield
-
P/E
(2.67)
Shares Outstanding
58,560,061
Open
$1.96
Previous Close
$1.97
Days Range
$1.84 - $2.01
52 week range
$1.08 - $2.70
Volume
933,156
Avg. Volume (30 days)
525,351
Market Cap
$115.36M
Dividend Yield
-
P/E
(2.67)
Shares Outstanding
58,560,061
FINANCIAL STATEMENTS FOR ATYR PHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ATYR PHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Broadfoot Jill MarieChief Financial OfficerFeb 06, 2024 Sale$1.691,5902,68720,821Feb 06, 2024, 08:18 PM
Shukla SanjayPresident and CEODec 12, 2023 Buy$1.1812,00014,136106,173Dec 12, 2023, 06:50 PM
Shukla SanjayPresident and CEODec 11, 2023 Buy$1.173,0003,51094,173Dec 12, 2023, 06:50 PM
Shukla SanjayPresident and CEONov 13, 2023 Buy$1.1113,57815,08591,173Nov 13, 2023, 04:11 PM
Shukla SanjayPresident and CEONov 10, 2023 Buy$1.141,4221,61877,595Nov 13, 2023, 04:11 PM
Shukla SanjayPresident and CEOJul 28, 2023 Buy$2.0115,00030,22376,173Aug 01, 2023, 04:07 PM
SCHIMMEL PAULDirectorMay 10, 2023 Buy$2.25200,000450,000313,023May 11, 2023, 09:00 AM
Broadfoot Jill MarieChief Financial OfficerFeb 06, 2023 Sale$2.361,5663,69615,460Feb 06, 2023, 07:00 PM
Shukla SanjayPresident and CEONov 21, 2022 Buy$2.1410,00021,40550,798Nov 21, 2022, 09:04 PM
Shukla SanjayPresident and CEOJul 01, 2022 Buy$2.8815,00043,16440,798Jul 06, 2022, 05:02 PM
Broadfoot Jill MarieChief Financial OfficerJan 13, 2022 Buy$6.751,92312,98012,112Jan 18, 2022, 08:39 AM
Shukla SanjayPresident and CEOJan 07, 2022 Buy$6.765,00033,80725,798Jan 10, 2022, 08:03 PM
Shukla SanjayPresident and CEONov 15, 2021 Buy$8.572,50021,43720,798Nov 15, 2021, 06:56 PM
SCHIMMEL PAULDirectorSep 20, 2021 Buy$8.00250,0002,000,000252,890Sep 22, 2021, 08:19 PM
SCHIMMEL PAULDirectorMay 18, 2021 Buy$3.9850,000199,000113,023May 20, 2021, 08:55 AM
Shukla SanjayPresident and CEOMay 18, 2021 Buy$4.0110,00040,10018,298May 20, 2021, 08:52 AM
Broadfoot Jill MarieChief Financial OfficerFeb 09, 2021 Sale$7.663902,9879,833Feb 09, 2021, 09:15 PM
Shukla SanjayPresident and CEOFeb 09, 2021 Sale$7.667785,9598,298Feb 09, 2021, 09:12 PM
CLARKE JOHN KDirectorAug 28, 2020 Sale$4.00100400117,843Sep 03, 2020, 09:47 PM
CLARKE JOHN KDirectorSep 02, 2020 Sale$4.017,26029,113110,583Sep 03, 2020, 09:47 PM
CLARKE JOHN KDirectorAug 27, 2020 Sale$4.095,44022,250117,943Aug 28, 2020, 09:09 PM
CLARKE JOHN KDirectorAug 26, 2020 Sale$4.302,2009,451123,383Aug 28, 2020, 09:09 PM
Broadfoot Jill MarieChief Financial OfficerJun 19, 2020 Buy$4.221,8507,8079,153Jun 23, 2020, 04:27 PM
Shukla SanjayPresident and CEOJun 19, 2020 Buy$4.276,00025,6207,291Jun 23, 2020, 04:23 PM
DENYES NANCYGeneral CounselMay 20, 2020 Sale$3.623221,1662,735May 28, 2020, 08:26 PM
SCHIMMEL PAULDirectorMay 20, 2020 Sale$3.648,44730,739429,143May 22, 2020, 08:13 PM
SCHIMMEL PAULDirectorFeb 10, 2020 Buy$4.25254,0001,079,500437,590Feb 11, 2020, 11:58 AM
Shukla SanjayPresident and CEOFeb 07, 2020 Sale$4.037453,0021,291Feb 07, 2020, 07:37 PM
Broadfoot Jill MarieChief Financial OfficerFeb 07, 2020 Sale$4.033751,5117,125Feb 07, 2020, 07:30 PM
Krueger NancyGeneral CounselMay 17, 2019 Sale$0.454,6512,09325,348May 20, 2019, 04:38 PM
SCHIMMEL PAULDirectorApr 12, 2019 Option Exercise$0.541,848,4281,000,0002,570,242Apr 16, 2019, 04:31 PM
MENDLEIN JOHNDirectorDec 21, 2018 Buy$0.42195,00082,602615,382Dec 26, 2018, 04:15 PM
MENDLEIN JOHNDirectorDec 20, 2018 Buy$0.4150,00020,645420,382Dec 26, 2018, 04:15 PM
SCHIMMEL PAULDirectorNov 26, 2018 Buy$0.54147,22579,796882,302Nov 28, 2018, 07:12 PM
Broadfoot Jill MarieChief Financial OfficerSep 20, 2018 Buy$0.8438,00031,73890,000Sep 21, 2018, 04:38 PM
Broadfoot Jill MarieChief Financial OfficerSep 19, 2018 Buy$0.8126,00021,11752,000Sep 21, 2018, 04:38 PM
Broadfoot Jill MarieChief Financial OfficerSep 14, 2018 Buy$0.7326,00019,05526,000Sep 18, 2018, 06:12 PM
SCHIMMEL PAULDirectorSep 04, 2018 Buy$0.7620,74915,709735,077Sep 05, 2018, 04:04 PM
SCHIMMEL PAULDirectorAug 31, 2018 Buy$0.7222,00015,752714,328Sep 05, 2018, 04:04 PM
SCHIMMEL PAULDirectorAug 30, 2018 Buy$0.7689,27567,483692,328Aug 31, 2018, 04:11 PM
SCHIMMEL PAULDirectorAug 29, 2018 Buy$0.7275,13654,090603,053Aug 31, 2018, 04:11 PM
SCHIMMEL PAULDirectorMay 18, 2018 Buy$1.00150,000149,445527,917May 21, 2018, 06:50 PM
EcoR1 Capital Fund Qualified, L.P.10% OwnerMay 16, 2018 Sale$0.812,733,2312,216,9240May 16, 2018, 05:15 PM
EcoR1 Capital Fund Qualified, L.P.10% OwnerMay 15, 2018 Sale$1.43121,294173,0622,733,231May 16, 2018, 05:15 PM
EcoR1 Capital Fund Qualified, L.P.10% OwnerMay 14, 2018 Sale$1.72354,791609,0702,854,525May 16, 2018, 05:15 PM
Blake John TSenior Vice President, FinanceFeb 08, 2018 Sale$3.401,4024,7671,932Feb 08, 2018, 08:43 PM
Amanullah AshrafSee RemarksFeb 08, 2018 Sale$3.401,4024,7671,932Feb 08, 2018, 08:39 PM
EcoR1 Capital Fund Qualified, L.P.10% OwnerOct 01, 2017 Buy$5.054,87924,6393,198,420Dec 14, 2017, 03:46 PM
EcoR1 Capital Fund Qualified, L.P.10% OwnerNov 01, 2017 Buy$4.8024,728118,6943,223,148Dec 14, 2017, 03:46 PM
EcoR1 Capital Fund Qualified, L.P.10% OwnerNov 13, 2017 Sale$3.951,0834,2783,209,316Dec 14, 2017, 03:46 PM
EcoR1 Capital Fund Qualified, L.P.10% OwnerNov 10, 2017 Sale$4.005,86023,4453,210,399Dec 14, 2017, 03:46 PM
EcoR1 Capital Fund Qualified, L.P.10% OwnerNov 09, 2017 Sale$4.155,81924,1513,216,259Dec 14, 2017, 03:46 PM
EcoR1 Capital Fund Qualified, L.P.10% OwnerNov 08, 2017 Sale$4.301,0704,6013,222,078Dec 14, 2017, 03:46 PM
SCHIMMEL PAULDirectorAug 31, 2017 Buy$2.6594,336249,990377,917Sep 05, 2017, 08:22 PM
MENDLEIN JOHNCEO and DirectorAug 31, 2017 Buy$2.6537,736100,000367,883Sep 05, 2017, 07:41 PM
MENDLEIN JOHNCEO and DirectorApr 24, 2017 Buy$3.00124372327,647Apr 26, 2017, 05:02 PM
MENDLEIN JOHNCEO and DirectorApr 20, 2017 Buy$3.001,5524,656327,523Apr 20, 2017, 07:04 PM
MENDLEIN JOHNCEO and DirectorApr 18, 2017 Buy$3.001,0003,000325,971Apr 20, 2017, 07:04 PM
SCHIMMEL PAULDirectorDec 21, 2016 Buy$2.2810,00022,818721,814Dec 22, 2016, 11:53 AM
SCHIMMEL PAULDirectorDec 20, 2016 Buy$2.2715,00034,110711,814Dec 22, 2016, 11:53 AM
Amanullah AshrafVice President, ManufacturingDec 20, 2016 Buy$2.2511,00024,74911,000Dec 21, 2016, 06:37 PM
MENDLEIN JOHNCEO and DirectorDec 19, 2016 Buy$2.2069,000151,662324,971Dec 21, 2016, 11:54 AM
SCHIMMEL PAULDirectorDec 16, 2016 Buy$2.4010,00023,973696,814Dec 19, 2016, 07:41 PM
SCHIMMEL PAULDirectorDec 15, 2016 Buy$2.5040,00099,912686,814Dec 19, 2016, 07:41 PM
Matsuoka GroveSee RemarksMay 09, 2016 Buy$3.082,4127,4292,412May 11, 2016, 08:54 PM
Matsuoka GroveSee RemarksMay 11, 2016 Buy$3.0310,00030,30012,412May 11, 2016, 08:54 PM
SCHIMMEL PAULDirectorApr 14, 2016 Buy$4.1432,600135,07553,012Apr 15, 2016, 05:46 PM
SCHIMMEL PAULDirectorApr 14, 2016 Buy$4.2233,619141,859283,581Apr 15, 2016, 05:46 PM
SCHIMMEL PAULDirectorApr 13, 2016 Buy$3.859,83537,865249,962Apr 14, 2016, 07:20 PM
SCHIMMEL PAULDirectorApr 12, 2016 Buy$3.706,54624,220240,127Apr 13, 2016, 06:34 PM
SCHIMMEL PAULDirectorApr 12, 2016 Buy$3.752,5819,68220,412Apr 13, 2016, 06:34 PM
SCHIMMEL PAULDirectorApr 11, 2016 Buy$3.5627,40097,643233,581Apr 13, 2016, 06:32 PM
SCHIMMEL PAULDirectorApr 11, 2016 Buy$3.595,25918,89117,831Apr 13, 2016, 06:32 PM
SCHIMMEL PAULDirectorApr 11, 2016 Buy$3.5732,659116,535220,231Apr 12, 2016, 03:57 PM
SCHIMMEL PAULDirectorApr 08, 2016 Buy$3.2285,000273,649187,572Apr 11, 2016, 12:39 PM
SCHIMMEL PAULDirectorApr 07, 2016 Buy$3.1940,000127,584102,572Apr 08, 2016, 12:19 PM
SCHIMMEL PAULDirectorApr 06, 2016 Buy$3.2025,00080,00062,572Apr 07, 2016, 03:40 PM
MENDLEIN JOHNCEO and DirectorApr 05, 2016 Buy$3.522,5008,800250,971Apr 07, 2016, 03:25 PM
MENDLEIN JOHNCEO and DirectorApr 05, 2016 Buy$3.552,5008,875248,471Apr 06, 2016, 07:19 PM
SCHIMMEL PAULDirectorApr 05, 2016 Buy$3.5225,00088,11737,572Apr 06, 2016, 07:19 PM
AKKARAJU SRINIVASDirectorMay 12, 2015 Buy$14.00320,0004,480,0001,866,126May 14, 2015, 09:24 PM
Sofinnova Venture Partners IX, L.P.10% OwnerMay 12, 2015 Buy$14.00320,0004,480,0001,866,126May 14, 2015, 09:19 PM
Flynn James E10% OwnerMay 12, 2015 Buy$14.0025,000350,000255,764May 13, 2015, 01:00 PM
Flynn James E10% OwnerMay 12, 2015 Buy$14.0025,000350,000255,764May 13, 2015, 01:00 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Broadfoot Jill MarieChief Financial Officer02/06/20242,687
Shukla SanjayPresident and CEO12/12/202314,136
Shukla SanjayPresident and CEO12/11/20233,510
Shukla SanjayPresident and CEO11/13/202315,085
Shukla SanjayPresident and CEO11/10/20231,618
Shukla SanjayPresident and CEO07/28/202330,223
SCHIMMEL PAULDirector05/10/2023450,000
Broadfoot Jill MarieChief Financial Officer02/06/20233,696
Shukla SanjayPresident and CEO11/21/202221,405
Shukla SanjayPresident and CEO07/01/202243,164
Broadfoot Jill MarieChief Financial Officer01/13/202212,980
Shukla SanjayPresident and CEO01/07/202233,807
Shukla SanjayPresident and CEO11/15/202121,437
SCHIMMEL PAULDirector09/20/20212,000,000
SCHIMMEL PAULDirector05/18/2021199,000
Shukla SanjayPresident and CEO05/18/202140,100
Broadfoot Jill MarieChief Financial Officer02/09/20212,987
Shukla SanjayPresident and CEO02/09/20215,959
CLARKE JOHN KDirector08/28/2020400
CLARKE JOHN KDirector09/02/202029,113
CLARKE JOHN KDirector08/27/202022,250
CLARKE JOHN KDirector08/26/20209,451
Broadfoot Jill MarieChief Financial Officer06/19/20207,807
Shukla SanjayPresident and CEO06/19/202025,620
DENYES NANCYGeneral Counsel05/20/20201,166
SCHIMMEL PAULDirector05/20/202030,739
SCHIMMEL PAULDirector02/10/20201,079,500
Shukla SanjayPresident and CEO02/07/20203,002
Broadfoot Jill MarieChief Financial Officer02/07/20201,511
Krueger NancyGeneral Counsel05/17/20192,093
SCHIMMEL PAULDirector04/12/20191,000,000
MENDLEIN JOHNDirector12/21/201882,602
MENDLEIN JOHNDirector12/20/201820,645
SCHIMMEL PAULDirector11/26/201879,796
Broadfoot Jill MarieChief Financial Officer09/20/201831,738
Broadfoot Jill MarieChief Financial Officer09/19/201821,117
Broadfoot Jill MarieChief Financial Officer09/14/201819,055
SCHIMMEL PAULDirector09/04/201815,709
SCHIMMEL PAULDirector08/31/201815,752
SCHIMMEL PAULDirector08/30/201867,483
SCHIMMEL PAULDirector08/29/201854,090
SCHIMMEL PAULDirector05/18/2018149,445
EcoR1 Capital Fund Qualified, L.P.10% Owner05/16/20182,216,924
EcoR1 Capital Fund Qualified, L.P.10% Owner05/15/2018173,062
EcoR1 Capital Fund Qualified, L.P.10% Owner05/14/2018609,070
Blake John TSenior Vice President, Finance02/08/20184,767
Amanullah AshrafSee Remarks02/08/20184,767
EcoR1 Capital Fund Qualified, L.P.10% Owner10/01/201724,639
EcoR1 Capital Fund Qualified, L.P.10% Owner11/01/2017118,694
EcoR1 Capital Fund Qualified, L.P.10% Owner11/13/20174,278
EcoR1 Capital Fund Qualified, L.P.10% Owner11/10/201723,445
EcoR1 Capital Fund Qualified, L.P.10% Owner11/09/201724,151
EcoR1 Capital Fund Qualified, L.P.10% Owner11/08/20174,601
SCHIMMEL PAULDirector08/31/2017249,990
MENDLEIN JOHNCEO and Director08/31/2017100,000
MENDLEIN JOHNCEO and Director04/24/2017372
MENDLEIN JOHNCEO and Director04/20/20174,656
MENDLEIN JOHNCEO and Director04/18/20173,000
SCHIMMEL PAULDirector12/21/201622,818
SCHIMMEL PAULDirector12/20/201634,110
Amanullah AshrafVice President, Manufacturing12/20/201624,749
MENDLEIN JOHNCEO and Director12/19/2016151,662
SCHIMMEL PAULDirector12/16/201623,973
SCHIMMEL PAULDirector12/15/201699,912
Matsuoka GroveSee Remarks05/09/20167,429
Matsuoka GroveSee Remarks05/11/201630,300
SCHIMMEL PAULDirector04/14/2016135,075
SCHIMMEL PAULDirector04/14/2016141,859
SCHIMMEL PAULDirector04/13/201637,865
SCHIMMEL PAULDirector04/12/201624,220
SCHIMMEL PAULDirector04/12/20169,682
SCHIMMEL PAULDirector04/11/201697,643
SCHIMMEL PAULDirector04/11/201618,891
SCHIMMEL PAULDirector04/11/2016116,535
SCHIMMEL PAULDirector04/08/2016273,649
SCHIMMEL PAULDirector04/07/2016127,584
SCHIMMEL PAULDirector04/06/201680,000
MENDLEIN JOHNCEO and Director04/05/20168,800
MENDLEIN JOHNCEO and Director04/05/20168,875
SCHIMMEL PAULDirector04/05/201688,117
AKKARAJU SRINIVASDirector05/12/20154,480,000
Sofinnova Venture Partners IX, L.P.10% Owner05/12/20154,480,000
Flynn James E10% Owner05/12/2015350,000
Flynn James E10% Owner05/12/2015350,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ATYR PHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.1,362,3600.00005%0.36%Other
RENAISSANCE TECHNOLOGIES LLC877,9720.00192%73.51%Other
GEODE CAPITAL MANAGEMENT, LLC586,9970.00009%No changeOther
CHANGE IN SHARES OUTSTANDING FOR ATYR PHARMA INC
STOCK BUYBACKS FOR ATYR PHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
4.97%
1Q

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
4.97%
1Q
BUYBACK ANNOUNCEMENT(S) FOR ATYR PHARMA INC
LOADING...